Vikas Sinha, EVP & CFO at Alexion Pharmaceuticals, holds 17.81M shares in AlloVir (Ticker: ALVR), holds 74.44K shares in Verona Pharma (Ticker: VRNA), holds 171.86K shares in Alexion Pharmaceuticals (Ticker: ALXN). Most recently, Vikas Sinha Sold ― shares of AlloVir on May 07, 2024 for an estimated value of 3.92K.